Anti-Müllerian hormone as a predictor of reproductive potential.
Leah Hawkins Bressler, Anne Steiner
https://pubmed.ncbi.nlm.nih.gov/30299431/Actively Recruiting
Led by Reproductive Medicine Associates of New Jersey · Updated on 2026-06-03
40
Participants Needed
1
Research Sites
17 weeks
Total Duration
Researchers are studying the elasticity of the female reproductive organs, including the uterus, cervix, and ovaries, by using shear wave elastography during different times of the menstrual cycle. The study aims to establish normal reference ranges for uterine and ovarian tissue stiffness. This knowledge may help in diagnosing and predicting outcomes for women seeking fertility treatments. The study involves measuring tissue stiffness with shear wave elastography, a device that uses ultrasound to assess elasticity in kilopascals. Participants are grouped into three categories women with normal menstrual cycles and no prior pregnancy or infertility women with normal cycles and at least one prior full-term vaginal delivery without infertility and women with normal cycles and diagnosed primary infertility without uterine factor infertility. Each participant undergoes this assessment over approximately 3 to 4 months from enrollment. Participants will be monitored through shear wave elastography measurements to observe changes throughout their menstrual cycles. The primary outcome is the elastography parameters recorded within 3 to 4 months. This observational study includes women aged 18 to 45 years with normal uterine and ovarian anatomy. The study also involves detailed eligibility assessments to ensure participants meet criteria related to menstrual cycle regularity, anatomy, and reproductive history.
CONDITIONS
Quantifying Uterine Elastography in Menstruating Women
C
Caroline Zuckerman, BS, BSN, RN
C
Christine Whitehead, MS, BSN, RN
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Reproductive Medicine Associates of New Jersey
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 3 to 4 months from enrollment
Participants undergo shear wave elastography measurements via ultrasound to assess uterine and ovarian tissue stiffness.
Multiple visits timed across the menstrual cycle
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Leah Hawkins Bressler, Anne Steiner
https://pubmed.ncbi.nlm.nih.gov/30299431/Juntao Shao, Guilian Shi, Zhengqin Qi...
https://pubmed.ncbi.nlm.nih.gov/34049726/Amr A Soliman, Sebastian Wojcinski, Friedrich Degenhardt
https://pubmed.ncbi.nlm.nih.gov/24840338/T Van den Bosch, A M de Bruijn, R A de Leeuw...
https://pubmed.ncbi.nlm.nih.gov/29790217/Abdussamet Batur, Alpaslan Yavuz, Mesut Ozgokce...
https://pubmed.ncbi.nlm.nih.gov/26880060/Francesca Barrett, Stephanie Willson, Marie Werner
https://pubmed.ncbi.nlm.nih.gov/38656810/Aysegul Altunkeser, Zeynep Ozturk Inal, Nahide Baran
https://pubmed.ncbi.nlm.nih.gov/32484092/Cihan Kabukçu, Ümit Çabuş, Özer Öztekin...
https://pubmed.ncbi.nlm.nih.gov/34254413/Nelly Swierkowski-Blanchard, Florence Boitrelle, Laura Alter...
https://pubmed.ncbi.nlm.nih.gov/28283264/Emily J Zaniker, Man Zhang, Lydia Hughes...
https://pubmed.ncbi.nlm.nih.gov/38609185/Reproductive Medicine Associates of New Jersey
Lead Sponsor